These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16967302

  • 1. Incident pain and analgesic consumption decrease after samarium infusion: a pilot study.
    Ripamonti C, Fagnoni E, Campa T, Seregni E, Maccauro M, Bombardieri E.
    Support Care Cancer; 2007 Mar; 15(3):339-42. PubMed ID: 16967302
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
    Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA.
    J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
    Sartor O, Reid RH, Bushnell DL, Quick DP, Ell PJ.
    Cancer; 2007 Feb 01; 109(3):637-43. PubMed ID: 17167764
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
    Macedo A, Araújo A, Melo FC, Nunes G, Cantinho G, Amorin I.
    Acta Med Port; 2006 Feb 01; 19(5):421-6. PubMed ID: 17376329
    [Abstract] [Full Text] [Related]

  • 8. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug 29; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.
    Menda Y, Bushnell DL, Williams RD, Miller S, Thomas MO.
    Clin Nucl Med; 2000 Sep 29; 25(9):698-700. PubMed ID: 10983757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.
    Dolezal J.
    Onkologie; 2009 Feb 29; 32(1-2):35-9. PubMed ID: 19209017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).
    Barnard SM, Zuber RM, Moore AS.
    J Am Vet Med Assoc; 2007 Jun 15; 230(12):1877-81. PubMed ID: 17571994
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.
    Lin J, Sinibaldi VJ, Carducci MA, Denmeade S, Song D, Deweese T, Eisenberger MA.
    Urol Oncol; 2011 Jun 15; 29(6):670-5. PubMed ID: 19962920
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P, Nuñez R.
    Expert Rev Anticancer Ther; 2007 Nov 15; 7(11):1517-27. PubMed ID: 18020921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.